![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 06, 2012 12:01:58 PM
Thats IMO is the only marketability interest for AQUAPRIN in the stock market interest/retail interest/medical field interest is if the claims are validated. Otherwise pharce buster IMO, you are dead right, the game will be over. This is IMO the last opportunity by PHAR to get this to market, based on its long history and still not to market.
I live in south and an old saying of putting wagon before the horse seems to hold true in PHARs/CEOs approach.
Why would you not FIRST get the VALUABLE tool of 3rd party validation in order to present to investors/financial institutions/medical market tour that this is the real deal, proven to do what it claims .
Would be less likely to get turned down over and over and over due to obvious risk factor, if it could possibly fail the claims validation by non in house 3rd party testing.
You and i would have a hard time getting a loan for a production facility to build gas engines that got 500 MPG based on word alone.
All the needed items, building,equipment, compliance mandates,marketing would IMO have a better chance by putting 3rd party claims FIRST PRIORITY.
GLTA
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM